Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應用
(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic Acid is a derivative of Sitagliptin (S491000), a dipeptidyl peptidase-4 inhibitor used to treat patients with type-2 diabetes by means of glycemic control.
參考文獻
Aschner, P., et al.: Diabetes Care, 29, 2632 (2006); Raz, I., et al.: Diabetologia, 49, 2564 (2006)
滬ICP備17019645號
400-821-0725
